Dare Bioscience, Inc. Finance Lease, Liability, Noncurrent
Dare Bioscience, Inc. (DARE) had Finance Lease, Liability, Noncurrent of $165.19 thousand as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:FinanceLeaseLiabilityNoncurrent · last filed 2025-11-13
- 2025-09-30: Finance Lease, Liability, Noncurrent $165.19K.
- 2025-06-30: Finance Lease, Liability, Noncurrent $164.41K.
- 2025-03-31: Finance Lease, Liability, Noncurrent $649.93K.
- 2024-12-31: Finance Lease, Liability, Noncurrent $0.00.
| Period end | Finance Lease, Liability, Noncurrent |
|---|---|
| 2025-09-30 | $165.19K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $164.41K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $649.93K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $0.00 10-Q · filed 2025-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |